Martin Kolář

810 total citations
35 papers, 402 citations indexed

About

Martin Kolář is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Martin Kolář has authored 35 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 13 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Martin Kolář's work include Inflammatory Bowel Disease (23 papers), Microscopic Colitis (11 papers) and Biosimilars and Bioanalytical Methods (7 papers). Martin Kolář is often cited by papers focused on Inflammatory Bowel Disease (23 papers), Microscopic Colitis (11 papers) and Biosimilars and Bioanalytical Methods (7 papers). Martin Kolář collaborates with scholars based in Czechia, United States and United Kingdom. Martin Kolář's co-authors include Jennifer Pearson, Kimberley Williams, Bill Reger, Milan Lukáš, Dana Ďuricová, Martin Bortlík, Karin Malíčková, Naděžda Machková, Martin Lukáš and Veronika Hrubá and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gastrointestinal Endoscopy.

In The Last Decade

Martin Kolář

26 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Kolář Czechia 8 163 126 94 65 51 35 402
Sharon Jedel United States 10 102 0.6× 128 1.0× 104 1.1× 9 0.1× 38 0.7× 17 368
Brooke Beatie Canada 9 79 0.5× 107 0.8× 101 1.1× 10 0.2× 11 0.2× 15 352
Bo Wei China 12 55 0.3× 42 0.3× 28 0.3× 13 0.2× 32 0.6× 26 421
Matthew T. Bernstein Canada 13 32 0.2× 219 1.7× 297 3.2× 32 0.5× 57 1.1× 28 716
Patricia Koochaki United States 13 296 1.8× 88 0.7× 51 0.5× 8 0.1× 30 0.6× 25 1.2k
Dieter Benninghoven Germany 12 208 1.3× 134 1.1× 110 1.2× 7 0.1× 45 0.9× 27 489
Maarit Virta Finland 12 52 0.3× 28 0.2× 45 0.5× 54 0.8× 30 0.6× 25 436
Sebastian Kunzendorf Germany 8 126 0.8× 107 0.8× 106 1.1× 7 0.1× 33 0.6× 14 348
Hugo Sjöqvist Sweden 13 127 0.8× 27 0.2× 69 0.7× 22 0.3× 5 0.1× 33 422
Marc Sidler Switzerland 9 23 0.1× 189 1.5× 96 1.0× 49 0.8× 19 0.4× 12 402

Countries citing papers authored by Martin Kolář

Since Specialization
Citations

This map shows the geographic impact of Martin Kolář's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Kolář with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Kolář more than expected).

Fields of papers citing papers by Martin Kolář

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Kolář. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Kolář. The network helps show where Martin Kolář may publish in the future.

Co-authorship network of co-authors of Martin Kolář

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Kolář. A scholar is included among the top collaborators of Martin Kolář based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Kolář. Martin Kolář is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukáš, Martin, et al.. (2025). VEDOLIZUMAB PLUS CURCUMIN-QINGDAI FOR PATIENTS WITH ULCERATIVE COLITIS. Inflammatory Bowel Diseases. 31(Supplement_1). S74–S74.
3.
Coufal, Štěpán, Miloslav Kverka, Jakub Kreisinger, et al.. (2023). Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD. Journal of Immunology Research. 2023. 1–16. 3 indexed citations
4.
Ďuricová, Dana, Martin Kolář, Naděžda Machková, et al.. (2023). Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?. Crohn s & Colitis 360. 5(4). otad040–otad040. 10 indexed citations
6.
Kolář, Martin, et al.. (2023). EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB IN REFRACTORY ULCERATIVE COLITIS PATIENTS – SINGLE CENTRE EXPERIENCE. Inflammatory Bowel Diseases. 29(Supplement_1). S78–S78.
7.
Rob, Filip, Martin Kolář, Jakub Kreisinger, et al.. (2023). Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy. Frontiers in Cellular and Infection Microbiology. 12. 1064537–1064537. 6 indexed citations
8.
Kolář, Martin, et al.. (2023). Force-free and autonomous active Brownian ratchets (a). Europhysics Letters (EPL). 142(3). 31001–31001. 1 indexed citations
9.
Lukáš, Milan, et al.. (2023). SUBCUTANEOUS INFLIXIMAB IN REFRACTORY CROHN'S DISEASE PATIENTS AFTER THE MULTIPLE TREATMENT FAILURES - SHORT TREATMENT OUTCOMES. Inflammatory Bowel Diseases. 29(Supplement_1). S76–S76.
10.
Rob, Filip, Zuzana Stehlíková, Jakub Kreisinger, et al.. (2022). Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study. PLoS ONE. 17(12). e0277576–e0277576. 4 indexed citations
11.
Roubalová, Radka, Martin Kolář, Zuzana Stehlíková, et al.. (2021). Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy. Cells. 10(11). 3188–3188. 21 indexed citations
12.
Lukáš, Martin, Martin Kolář, O Ryska, et al.. (2021). A novel postgraduate endoscopic course using a large animal model of secondary Crohn's disease stricture. Surgical Endoscopy. 35(6). 3199–3204. 1 indexed citations
13.
Park, Sang Hyoung, et al.. (2020). Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases. Intestinal Research. 18(1). 34–44. 19 indexed citations
14.
Lukáš, Martin, Martin Kolář, O Ryska, et al.. (2020). Novel porcine model of Crohn's disease anastomotic stricture suitable for evaluation and training of advanced endoscopic techniques. Gastrointestinal Endoscopy. 93(1). 250–256. 6 indexed citations
15.
Kolář, Martin, et al.. (2019). The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study. Biomedical Papers. 164(2). 154–160. 4 indexed citations
16.
Kolář, Martin, Dana Ďuricová, Martin Bortlík, et al.. (2019). Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice. 73(1). 25–31. 3 indexed citations
17.
Malíčková, Karin, Milan Lukáš, Martin Kolář, et al.. (2017). Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers. Practical Laboratory Medicine. 9. 39–44. 51 indexed citations
18.
Bortlík, Martin, Dana Ďuricová, Naděžda Machková, et al.. (2015). Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation. Scandinavian Journal of Gastroenterology. 51(2). 196–202. 39 indexed citations
19.
Kolář, Martin, et al.. (2008). Dymanics of matrix-metalloproteinase 9 after brain trauma – results of a pilot study. Acta neurochirurgica. Supplementum. 102. 373–376. 7 indexed citations
20.
Williams, Kimberley, Martin Kolář, Bill Reger, & Jennifer Pearson. (2001). Evaluation of a Wellness-Based Mindfulness Stress Reduction Intervention: A Controlled Trial. American Journal of Health Promotion. 15(6). 422–432. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026